Phase Ia/Ib Multicenter Trial of Mogamulizumab for Advanced or Recurrent Cancer.

NCT01929486 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor

Interventions

BIOLOGICAL: Mogamulizumab

Sponsor

Aichi Medical University